All conditions with mutant IDH had elevated levels of global methylation, and when the DNA methylation data of the NSCs with mutant IDH were compared with human low-grade glioma from TCGA [65], there was clustering of IDH1-mutant gliomas with IDH-mutant NSCs. This evidence concerns the gene IDH1 and central nervous system cancer.